Zacks
Spotlight on Health ETFs as NVO & LLY Cut Obesity Drug Price in China
📉
AI Sentiment
Negative
3/10
- Home
- NVS
NVS
Novartis AG
as of 01-06-2026 3:55pm EST
$142.40
+$4.49
+3.26%
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
| Founded: | 1895 | Country: | Switzerland |
| Employees: | N/A | City: | N/A |
| Market Cap: | 266.5B | IPO Year: | 1991 |
| Target Price: | $118.00 | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | Hold | Number of Analysts: | 4 |
| Dividend Yield: | Dividend Payout Frequency: | Annual | |
| EPS: | 7.30 | EPS Growth: | -14.91 |
| 52 Week Low/High: | $97.39 - $140.18 | Next Earning Date: | 01-30-2026 |
| Revenue: | $56,372,000,000 | Revenue Growth: | 12.88% |
| Revenue Growth (this year): | 9.38% | Revenue Growth (next year): | 2.69% |
AI-Powered NVS Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 77.42%
77.42%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Novartis AG News
NVS Breaking Stock News: Dive into NVS Ticker-Specific Updates for Smart Investing
MT Newswires
Sector Update: Health Care Stocks Softer Late Afternoon
📉
AI Sentiment
Negative
3/10
MT Newswires
Sector Update: Health Care Stocks Softer Wednesday Afternoon
📉
AI Sentiment
Negative
3/10
MT Newswires
Market Chatter: Pfizer, GSK, Others to Raise US Prices on 350 Drugs in 2026
âž–
AI Sentiment
Neutral
5/10
Compare NVS vs Leading Stocks
See how NVS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "NVS Novartis AG - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.